| 生物活性 |
Tepilukimig is a bivalent humanized IgG1κ monoclonal antibody inhibitor targeting TSLP-IL7Rα and TSLP-CRLF2. Tepilukimig inhibits the binding of TSLP to its receptors (IL7Rα and CRLF2) on the cell surface, thereby completely interrupting the inflammatory signaling pathway driven by TSLP. Tepilukimig can be used for allergic and inflammatory diseases like atopic dermatitis and asthma research.
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAS号 |
2985643-31-8
|
||||||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
||||||||||||
| 储存方式 |
|
咨询热线：
400-881-9290
Data Sheet
